Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study

PHASE3CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

June 30, 2003

Conditions
Lupus Nephritis
Interventions
DRUG

tacrolimus

Trial Locations (7)

Unknown

Chubu Region

Hokkaido Region

Hokuriku Region

Kansai Region

Kanto Region

Shikoku Region

Tohoku Region

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY